Coherus Biosciences financial statements

코히러스 온콜로지NASDAQ:CHRS · Nasdaq · Healthcare · sector #13
$1.12-3.45%
2026-10-05 close

Coherus Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $267M. 2024 operating profit was $52M.

Reported results

Coherus Biosciences notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q